Literature DB >> 29196028

Serum Response Factor Promotes Dopaminergic Neuron Survival via Activation of Beclin 1-Dependent Autophagy.

Xiao-Yu Cheng1, Si-Yue Li2, Cheng-Jie Mao3, Mei-Xia Wang4, Jing Chen5, Fen Wang6, Guang-Hui Wang7, Wen-Bin Deng8, Xiao-Kang Li9, Chun-Feng Liu10.   

Abstract

Serum response factor (SRF), a transcription factor highly expressed in neurons, is involved in neuronal survival and the pathogenesis of some neurodegenerative disorders. The ablation of SRF renders the midbrain dopaminergic (DA) neurons vulnerable to 1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine-induced neurotoxicity, however, the underlying mechanisms remain poorly understood. Here, we report decreased SRF levels in the substantia nigra (SN) of rotenone-treated rats that was associated with the loss of tyrosine hydroxylase (TH)-positive neurons. SRF expression was also reduced in rotenone-treated PC12 cells in vitro. In addition, Srf knockdown augmented rotenone-induced toxicity in PC12 cells. In contrast, overexpression of Srf attenuated the cells' sensitivity to rotenone and alleviated rotenone-induced α-synuclein accumulation. The protective effect of SRF was abolished when the expression of autophagy-related proteins Beclin 1 and Atg5 was suppressed. These results suggested that SRF may promote DA neuron survival by regulating autophagy, and thus serves as a critical molecule in PD progression.
Copyright © 2017 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Beclin 1; Parkinson’s disease; autophagy; dopaminergic neuron; serum response factor

Mesh:

Substances:

Year:  2017        PMID: 29196028     DOI: 10.1016/j.neuroscience.2017.11.040

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  1 in total

1.  Corticosterone induces neurotoxicity in PC12 cells via disrupting autophagy flux mediated by AMPK/mTOR signaling.

Authors:  Run-Dong Ma; Gui-Juan Zhou; Miao Qu; Ji-Hong Yi; Ya-Ling Tang; Xiang-Yi Yang; Ya-Xiong Nie; Hong-Feng Gu
Journal:  CNS Neurosci Ther       Date:  2019-08-18       Impact factor: 5.243

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.